http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
증례 : βM - Component 를 정시한 IgA Myeloma 3 예보고
김상인 ( Sang In Kim ),한심석 ( Shim Suk Hahn ),김정용 ( Chung Yong Kim ),최동엽 ( Dong Yup Choi ),김재하 ( Jae Ha Kim ),김노경 ( Noe Kyeong Kim ) 대한내과학회 1968 대한내과학회지 Vol.11 No.10
3 cases of IgA myeloma showing βM-component confirmed by hematologic and immunoelectrophoretic method is presented. The common chief complaints were headache, bone pain and those associated with the symptoms of anemia. Marked anemia with leukopenia and ele
간경변증 , 만성위염 및 기타 내과영역환자에 대한 단백동화 Steroid Nandrolone Phenylpropionate ( Durabolin R ) 의 효과
김노경 ( Noe Kyeong Kim ),김용태 ( Yong Tae Kim ) 대한내과학회 1969 대한내과학회지 Vol.12 No.7
The therapeutic effects of anabolic steroid (nandrolone phenylpropionate: Durabolin) in the cases of liver cirrhosis, chronic nephritis and other diseases. Nandrolone phenylpropionate (Durabolin), an anabolic steroid, was clinically evaluated in 89 patient
전이성 유방암에 대한 Cyclophosphamide , Adriamycin , Methotrexate , 5 - FU ( CAMF ) 4 제 복합화학요법
김시영(Si Young Kim),김흥태(Heung Tae Kim),강윤구(Yoon Koo Kang),서철원(Cheol Won Suh),방영주(Yung Jue Bang),김노경(Noe Kyeong Kim),이건욱(Kun Uk Lee),최국진(Kuk Jin Choe),김수태(Soo Tae Kim) 대한내과학회 1988 대한내과학회지 Vol.34 No.6
N/A Between November, 1984 and January, 1987 32 patietns with metastatic breast cancer were treated with CAMF combination chemotherapy. Median age waa 45. Fourteen patients had prior chemotherapy and 2 patients had prior endocrine therapy. The menopausal status was as follows; 13 patients were postmenopausal, 19 premenopausal. The performance status was grade 0 to 1 (ECOG) in 13 patients, 2 in 12 and 3 in 7. Treatment was cyclophosphamide 750mg/m iv, day 1, adriamycin 30mg/㎟ iv, day 1; methotrexate 40mg/㎟ iv, day 8, and 5-FV 500 mg/㎟ iv, day 9. The treatment was recycled every 4 weeks until the progression of disease. Among 32 patients, 18 (56%) achived responses (1 CR and 17 RP), Median duration of response was 9 months. Median survival for all patients was 12 months. Toxicity was as follows; leukopenia 56 %, thrombocytopenia 15%, N/V 63%. No treatmentrelated death was observed during the treatment. It was concluded that CAMF combination chemotherapy is not superior to other cornbination chemotherapy regiments, and myelosuppression is a major dose-limiting toxicity.